Reuters logo
in 7 months
BRIEF-Syndax Pharmaceuticals, National Cancer Institute collaborate to develop cancer treatments
December 14, 2016 / 12:15 PM / in 7 months

BRIEF-Syndax Pharmaceuticals, National Cancer Institute collaborate to develop cancer treatments

1 Min Read

Dec 14 (Reuters) - Syndax Pharmaceuticals Inc

* Syndax Pharmaceuticals announces collaboration with the National Cancer Institute to develop entinostat and SNDX-6352 for the treatment of cancer Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below